189 related articles for article (PubMed ID: 17382765)
1. Multivariate analysis of factors predicting success with dextranomer/hyaluronic acid injection for vesicoureteral reflux.
Yucel S; Gupta A; Snodgrass W
J Urol; 2007 Apr; 177(4):1505-9. PubMed ID: 17382765
[TBL] [Abstract][Full Text] [Related]
2. Learning from the learning curve: factors associated with successful endoscopic correction of vesicoureteral reflux using dextranomer/hyaluronic acid copolymer.
Dave S; Lorenzo AJ; Khoury AE; Braga LH; Skeldon SJ; Suoub M; Farhat W; Pippi Salle JL; Bägli DJ
J Urol; 2008 Oct; 180(4 Suppl):1594-9; discussion 1599-600. PubMed ID: 18710756
[TBL] [Abstract][Full Text] [Related]
3. Intra-orifice versus hydrodistention implantation technique in dextranomer/hyaluronic acid injection for vesicoureteral reflux.
Gupta A; Snodgrass W
J Urol; 2008 Oct; 180(4 Suppl):1589-92; discussion 1592-3. PubMed ID: 18710753
[TBL] [Abstract][Full Text] [Related]
4. Multivariate comparison of the efficacy of intraureteral versus subtrigonal techniques of dextranomer/hyaluronic acid injection.
Routh JC; Reinberg Y; Ashley RA; Inman BA; Wolpert JJ; Vandersteen DR; Husmann DA; Kramer SA
J Urol; 2007 Oct; 178(4 Pt 2):1702-5; discussion 1705-6. PubMed ID: 17707019
[TBL] [Abstract][Full Text] [Related]
5. The role of intraoperative cystography following the injection of dextranomer/hyaluronic acid copolymer.
Palmer LS
J Urol; 2008 Mar; 179(3):1118-20; discussion 1121. PubMed ID: 18206944
[TBL] [Abstract][Full Text] [Related]
6. Febrile urinary tract infections after ureteroneocystostomy and subureteral injection of dextranomer/hyaluronic acid for vesicoureteral reflux--do choice of procedure and success matter?
Dwyer ME; Husmann DA; Rathbun SR; Weight CJ; Kramer SA
J Urol; 2013 Jan; 189(1):275-82. PubMed ID: 23174239
[TBL] [Abstract][Full Text] [Related]
7. Subureteral injection of Deflux for correction of reflux: analysis of factors predicting success.
Lavelle MT; Conlin MJ; Skoog SJ
Urology; 2005 Mar; 65(3):564-7. PubMed ID: 15780377
[TBL] [Abstract][Full Text] [Related]
8. Single center experience with endoscopic subureteral dextranomer/hyaluronic acid injection as first line treatment in 1,551 children with intermediate and high grade vesicoureteral reflux.
Puri P; Kutasy B; Colhoun E; Hunziker M
J Urol; 2012 Oct; 188(4 Suppl):1485-9. PubMed ID: 22906657
[TBL] [Abstract][Full Text] [Related]
9. Subureteral injection of dextranomer/hyaluronic acid copolymer for persistent vesicoureteral reflux following ureteroneocystostomy.
Jung C; DeMarco RT; Lowrance WT; Pope JC; Adams MC; Dietrich MS; Brock JW
J Urol; 2007 Jan; 177(1):312-5. PubMed ID: 17162075
[TBL] [Abstract][Full Text] [Related]
10. Dextranomer/hyaluronic acid endoscopic injection is effective in the treatment of intermediate and high grade vesicoureteral reflux in patients with complete duplex systems.
Hunziker M; Mohanan N; Puri P
J Urol; 2013 May; 189(5):1876-81. PubMed ID: 23159268
[TBL] [Abstract][Full Text] [Related]
11. Urinary tract infection following successful dextranomer/hyaluronic acid injection for vesicoureteral reflux.
Chi A; Gupta A; Snodgrass W
J Urol; 2008 May; 179(5):1966-9. PubMed ID: 18355849
[TBL] [Abstract][Full Text] [Related]
12. Can we rely on the presence of dextranomer-hyaluronic acid copolymer mounds on ultrasound to predict vesicoureteral reflux resolution after injection therapy?
Zamilpa I; Koyle MA; Grady RW; Joyner BD; Shnorhavorian M; Lendvay TS
J Urol; 2011 Jun; 185(6 Suppl):2536-41. PubMed ID: 21555031
[TBL] [Abstract][Full Text] [Related]
13. Outcome analysis of mini-ureteroneocystostomy versus dextranomer/hyaluronic acid copolymer injection for unilateral vesicoureteral reflux.
Ashley R; Vandersteen D
J Urol; 2008 Oct; 180(4 Suppl):1611-3; discussion 1614. PubMed ID: 18710741
[TBL] [Abstract][Full Text] [Related]
14. Long-term followup of dextranomer/hyaluronic acid injection for vesicoureteral reflux: late failure warrants continued followup.
Lee EK; Gatti JM; Demarco RT; Murphy JP
J Urol; 2009 Apr; 181(4):1869-74; discussion 1874-5. PubMed ID: 19233403
[TBL] [Abstract][Full Text] [Related]
15. Treatment of pediatric vesicoureteral reflux using endoscopic injection of hyaluronic acid/dextranomer gel: intermediate-term experience by a single surgeon.
Hsieh MH; Madden-Fuentes RJ; Lindsay NE; Roth DR
Urology; 2010 Jul; 76(1):199-203. PubMed ID: 20035980
[TBL] [Abstract][Full Text] [Related]
16. Postoperative ureteral obstruction after subureteral injection of dextranomer/hyaluronic Acid copolymer.
Vandersteen DR; Routh JC; Kirsch AJ; Scherz HC; Ritchey ML; Shapiro E; Wolpert JJ; Pfefferle H; Reinberg Y
J Urol; 2006 Oct; 176(4 Pt 1):1593-5. PubMed ID: 16952696
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic Injection of Dextranomer/Hyaluronic Acid as First Line Treatment in 851 Consecutive Children with High Grade Vesicoureteral Reflux: Efficacy and Long-Term Results.
Friedmacher F; Colhoun E; Puri P
J Urol; 2018 Sep; 200(3):650-655. PubMed ID: 29551405
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic treatment of vesicoureteral reflux associated with paraureteral diverticula in children.
Cerwinka WH; Scherz HC; Kirsch AJ
J Urol; 2007 Oct; 178(4 Pt 1):1469-73. PubMed ID: 17706704
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for urinary tract infection after dextranomer/hyaluronic acid endoscopic injection.
Traxel E; DeFoor W; Reddy P; Sheldon C; Minevich E
J Urol; 2009 Oct; 182(4 Suppl):1708-12. PubMed ID: 19692024
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of concomitant autologous blood and dextranomer/hyaluronic acid copolymer injection to correct vesicoureteral reflux.
Kajbafzadeh AM; Tourchi A
J Urol; 2012 Sep; 188(3):948-52. PubMed ID: 22819104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
